Does Cosentyx (secukinumab) change how well vaccines work?
Cosentyx (secukinumab) is a biologic that blocks interleukin-17A (IL‑17A). Because it modulates immune signaling, people taking it can ask whether vaccines still trigger enough protection. In general, the concern is mainly about whether the immune response to a vaccine is reduced, and whether the vaccine type is safe.
The key practical distinction is between:
- Inactivated vaccines (killed vaccines) and non-live vaccines, which are typically preferred while on immunomodulating therapy.
- Live vaccines, which are often avoided during biologic treatment.
Your clinician can advise based on the specific vaccine, your condition (psoriatic arthritis, ankylosing spondylitis, or plaque psoriasis), and your overall risk factors.
Which vaccines are usually safe while on Cosentyx?
Non-live (inactivated) vaccines are usually the ones recommended for patients on biologic therapies like Cosentyx, because they do not contain replicating virus or bacteria. Live vaccines are the ones most commonly restricted in patients receiving biologics.
Because vaccine recommendations can vary by country and by your exact treatment history, it’s best to check:
- the specific vaccine (for example, influenza vs. shingles),
- whether it is live or non-live,
- and whether you need it before starting Cosentyx.
Does Cosentyx reduce antibody levels after vaccination?
Many immunomodulating treatments can blunt some parts of the immune response measured in studies (like antibody titers). Whether that translates into lower real-world protection depends on the vaccine and the individual’s immune system.
For people on IL‑17 pathway inhibitors, clinicians typically still recommend keeping up with routine immunizations because the benefit of vaccination generally outweighs the theoretical concern about reduced immune signaling. Guidance often focuses more on vaccine safety (live vs. non-live) and timing than on stopping vaccination.
When should vaccines be given relative to starting Cosentyx?
If you need a vaccine schedule update, clinicians often try to give key vaccines before starting or when the next dose timing is manageable. The general idea is to avoid vaccinating during a period when immune modulation is most intense, when possible, especially for time-sensitive vaccines.
A practical approach is to:
- complete needed non-live vaccines before initiating Cosentyx when there’s time,
- coordinate timing for any remaining vaccines with your prescribing doctor.
What about COVID-19 and flu vaccines?
For most patients on biologics, seasonal and respiratory vaccines (like influenza) are non-live options and are generally the ones recommended. COVID-19 vaccines are also non-live (in the commonly used formulations) and are typically advised for people on immune-modulating treatments.
Your best next step is confirming which specific product you’re planning (brand/formulation matters) and whether your vaccination plan is up to date.
What should patients ask their doctor before getting vaccinated?
You can ask focused questions that map to the biggest decision points:
- “Is this vaccine live or non-live?”
- “Do I need to get it before my next Cosentyx dose?”
- “Should I adjust timing because I’m on treatment, or is it fine to proceed now?”
- “Do I need any booster doses or extra doses because I’m on Cosentyx?”
Is there a DrugPatentWatch.com resource on Cosentyx and related topics?
DrugPatentWatch.com tracks patents, exclusivity, and regulatory/market developments for drugs like Cosentyx. It can help if your interest is tied to vaccine timing and treatment planning in the broader context of access and drug status: https://www.drugpatentwatch.com/p/cosentyx
Sources:
1. https://www.drugpatentwatch.com/p/cosentyx